| 000 | 01732 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512003013.0 | ||
| 264 | 0 | _c19900206 | |
| 008 | 199002s 0 0 eng d | ||
| 022 | _a0160-2446 | ||
| 024 | 7 |
_a10.1097/00005344-198911000-00009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeForrest, J M | |
| 245 | 0 | 0 |
_aFosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _cNov 1989 |
||
| 300 |
_a730-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xphysiopathology |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBradykinin _xblood |
| 650 | 0 | 4 |
_aCaptopril _xpharmacology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aFosinopril |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrganophosphorus Compounds _xpharmacology |
| 650 | 0 | 4 |
_aProline _xanalogs & derivatives |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aSympathetic Nervous System _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aWaldron, T L | |
| 700 | 1 | _aHarvey, C | |
| 700 | 1 | _aScalese, B | |
| 700 | 1 | _aRubin, B | |
| 700 | 1 | _aPowell, J R | |
| 700 | 1 | _aPetrillo, E W | |
| 700 | 1 | _aCushman, D W | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 14 _gno. 5 _gp. 730-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005344-198911000-00009 _zAvailable from publisher's website |
| 999 |
_c2487191 _d2487191 |
||